Transplantation of Unique, Newly Discovered Stem Cells May Lead to Promising Stroke Therapy
Restoring hopes that stem cell transplantation can aid in stroke recovery despite cellular irregularities, new evidence has surfaced that a new type of cell may be used to reduce the overall risks and complications. A joint team of Japanese and American researchers reported in the journal Stem Cells that multi-lineage-differentiating stress-enduring (Muse) cells are “unique stem cells that are able to self-renew and also display high efficiency for differentiating into neuron-like cells.” The researchers also explained that, unlike mesenchymal stem cells (MSCs) that have previously been used in stem cell transplantation in stroke-related clinical trials, in the present study, Muse cells were found to possess functional characteristics of neurons as they attain the attributes of the host microenvironment. “When Muse cells were transplanted into to the brains of rats modeled with stroke, they attained neuronal characteristics,” said the study’s lead researcher. To learn more about this study, click here.
Spine World Summit
Jan. 26, 2018 - Jan. 27, 2018; Hong Kong
6th Ottawa Neurosurgery Review Course
Feb. 3, 2018 - Feb. 10, 2018; Ottawa, ON Canada
Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.
69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR
Second International Brain Mapping Course
April 26-27, 2018; New Orleans